NASD · Basic Materials · Other Precious Metals & Mining · USA
Greenland Mines Ltd is a micro cap company (market value under $300 million) in the Other Precious Metals & Mining industry.
Greenland Mines Ltd develops medicines for chronic diseases including cancer, cardiovascular, and neurodegenerative disorders. The company operates through acquired platforms: a generic drug portfolio and biosimilar biologics for cancer treatment, and a proprietary gene therapy platform using a therapeutic protein called Klotho for neurodegenerative diseases. It holds market approvals for anti-cancer drugs in Germany.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Greenland Mines Ltd stock.
Not valued: We cannot value this company yet.
All 17 Other Precious Metals & Mining stocks
2 more in this industry show a wider margin of safety.
We do not publish a verdict on GRML yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.
We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.